ATC code L01
Abemaciclib
Aclarubicin
Acyclovir
Adagrasib
Adenosine deaminase inhibitor
Aflibercept
Alitretinoin
Alkyl sulfonate
Alkylating antineoplastic agent
Alpelisib
Altretamine
Alvocidib
American Society of Health-System Pharmacists
Aminolevulinic acid
Aminopterin
Amrubicin
Amsacrine
Anagrelide
Anatomical Therapeutic Chemical Classification System
Anthracycline
Anthraquinone
Anti-cancer medication
Antifolate
Antimetabolite
Antineoplastic
Arsenic trioxide
Asparaginase
Asparagine
Asthenia
Atrasentan
Axicabtagene ciloleucel
Azacitidine
Aziridine
Belinostat
Belotecan
Belzutifan
Bendamustine
Bexarotene
Bibcode (identifier)
Biological half-life
Bisantrene
Bleomycin
Bone marrow transplantation
Boron
Boronic acid
Bortezomib (data page)
Brexucabtagene autoleucel
Busulfan
CAS Registry Number
Cabazitaxel
Camptotheca
Camptothecin
Capecitabine
Carboplatin
Carboquone
Carboxylic acid
Carfilzomib
Carmofur
Carmustine
Celecoxib
Cell-cycle nonspecific antineoplastic agents
ChEMBL
ChemSpider
Chemical formula
Chemotherapy
Chlorambucil
Chlormethine
Ciltacabtagene autoleucel
Cisplatin
Cladribine
Clinical trial
Clofarabine
CompTox Chemicals Dashboard
Copanlisib
Cositecan
Crisnatol
Crosslinking of DNA
Cyclin-dependent kinase
Cyclophosphamide
Cytarabine
Cytochrome P450 oxidase
DNA polymerase inhibitor
DNA replication
Dacarbazine
Dactinomycin
DailyMed
Daunorubicin
Daunorubicin/cytarabine
Decitabine
Demecolcine
Denileukin diftitox
Deoxyribonucleotide
Dexamethasone
Dicycloplatin
Dihydrofolate reductase inhibitor
Dipeptide
Docetaxel
Doi (identifier)
Doxifluridine
Doxorubicin
DrugBank
Drug metabolism
Drug nomenclature
Drugs.com
Duvelisib
ECHA InfoCard
Efaproxiral
Eflornithine
Elesclomol
Elsamitrucin
Enasidenib
Endothelin receptor antagonist
Entinostat
Enzyme inhibitor
Epacadostat
Epigallocatechin gallate
Epirubicin
Epothilone
Eribulin
Estramustine phosphate
Etirinotecan pegol
Etoglucid
Etoposide
European Medicines Agency
Exatecan
Farnesyltransferase inhibitor
Floxuridine
Fludarabine
Fluorouracil
Food and Drug Administration
Fotemustine
Fuzuloparib
Gastrointestinal tract
Gemcitabine
Generic medication
Gimatecan
Glasdegib
Guide to Pharmacology
Halogenation
Hdl (identifier)
Heart failure
Histone deacetylase inhibitor
Hydrazine
Hydroxycarbamide
Hypomethylating agent
IMP dehydrogenase
ISSN (identifier)
Idarubicin
Idecabtagene vicleucel
Idelalisib
Ifosfamide
Imetelstat
Inavolisib
Intercalation (biochemistry)
International Chemical Identifier
Intravenous therapy
Irinotecan
Isocitrate dehydrogenase
Ivosidenib
Ixabepilone
Ixazomib
JSmol
KEGG
Larotaxel
Lenalidomide
Leucine
Lifileucel
Lipoxygenase inhibitor
Lisocabtagene maraleucel
List of withdrawn drugs
Liver
Lomustine
Lonidamine
Losoxantrone
Low blood pressure
Low platelets
Low white blood cells
Lucanthone
Lurbinectedin
Lurtotecan
M phase
Mannosulfan
Mantle cell lymphoma
Masoprocol
MedlinePlus
Melphalan
Melphalan flufenamide
Menogaril
Mercaptopurine
Methotrexate
Methyl aminolevulinate
Microtubule
Millennium Pharmaceuticals
Mitobronitol
Mitoguazone
Mitomycins
Mitotane
Mitotic inhibitor
Mitoxantrone
Mitozolomide
Molar mass
Multiple myeloma
Myelosuppression
NICE
Nadofaragene firadenovec
Navitoclax
Nedaplatin
Nelarabine
Neuropathy
Neutropenia
Nimustine
Niraparib
Niraparib/abiraterone acetate
Nitrogen mustard
Nitrosourea
Obecabtagene autoleucel
Oblimersen
Olaparib
Olutasidenib
Omacetaxine mepesuccinate
Oprozomib
Ortataxel
Oxaliplatin
PARP inhibitor
PMC (identifier)
PMID (identifier)
Paclitaxel
Padeliporfin
Palbociclib
Panobinostat
Pegaspargase
Pemetrexed
Pentostatin
Peripheral neuropathy
Pharmacodynamics
Pharmacokinetics
Phases of clinical research
Phenylalanine
Phosphodiesterase inhibitor
Phosphoinositide 3-kinase inhibitor
Photodynamic therapy
Photosensitizer
Pipobroman
Pirarubicin
Pixantrone
Plasma protein binding
Platinum-based antineoplastic
Plicamycin
Plitidepsin
Podophyllum peltatum
Porfimer sodium
Porphyrin
Pralatrexate
Prednimustine
Prednisone
Pregnancy category
Prescription drug
Procarbazine
Prophylaxis
Proteasome
Proteasome inhibitor
Protein Data Bank
Protein kinase inhibitor
PubChem
Public domain
Purine analogue
Pyrazinoic acid
Pyrimidine analogue
Rabacfosadine
Raltitrexed
Ranimustine
Receptor antagonist
Regulation of therapeutic goods
Retinoid
Retinoid X receptor
Reversible posterior leukoencephalopathy syndrome
Ribociclib
Ribonucleotide reductase inhibitor
Romidepsin
Route of administration
Rubitecan
Rucaparib
S2CID (identifier)
S phase
Satraplatin
Seliciclib
Selinexor
Semustine
Sex steroid
Shingles
Side effects
Silatecan
Simplified molecular-input line-entry system
Sitimagene ceradenovec
Sotorasib
Spindle poison
Standard for the Uniform Scheduling of Medicines and Poisons
Streptomyces
Streptozotocin
Subcutaneous administration
Tabelecleucel
Tagraxofusp
Talaporfin
Talimogene laherparepvec
Taxane
Tazemetostat
Tebentafusp
Tegafur
Tegafur/gimeracil/oteracil
Temoporfin
Temozolomide
Teniposide
Tesetaxel
Testolactone
Thiopurine
Thiotepa
Threonine
Thrombocytopenia
Thymidylate synthase inhibitor
Tiazofurin
Tiazofurine
Tigilanol tiglate
Time to progression
Tioguanine
Tipifarnib
Tisagenlecleucel
Topoisomerase inhibitor
Topotecan
Trabectedin
Treosulfan
Tretinoin
Triazene
Triaziquone
Triethylenemelamine
Trofosfamide
Tumour lysis syndrome
Type II topoisomerase
Type I topoisomerase
Ubiquitin
Umbralisib
Unique Ingredient Identifier
Uramustine
Valrubicin
Veliparib
Venetoclax
Verdinexor
Verteporfin
Vinblastine
Vinca alkaloid
Vincristine
Vindesine
Vinflunine
Vinorelbine
Vorasidenib
Vorinostat
Vosaroxin
WHO Model List of Essential Medicines
World Health Organization
Yeast
Zorubicin